VistaGen Therapeutics (VTGN)

• Market cap: $25M
• 1 day: -0.52%
• 5 days: -0.71%
• 1 month: 5.72%
• 3 months: 5.65%
• 6 months: -85.78%
• Year to date: -7.22%
• 1 year: -75.29%
• 5 years: -99.19%
• 10 years: -99.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59